<VariationArchive VariationID="1460139" VariationName="NC_000003.11:g.(?_180707368)_(180707390_?)del" VariationType="Deletion" Accession="VCV001460139" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1481496" VariationID="1460139">
      <GeneList>
        <Gene Symbol="DNAJC19" FullName="DnaJ heat shock protein family (Hsp40) member C19" GeneID="131118" HGNC_ID="HGNC:30528" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3q26.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="180983709" stop="180989838" display_start="180983709" display_stop="180989838" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="180701496" stop="180707561" display_start="180701496" display_stop="180707561" Strand="-" />
          </Location>
          <OMIM>608977</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000003.11:g.(?_180707368)_(180707390_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3q26.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" innerStart="180707368" innerStop="180707390" display_start="180707368" display_stop="180707390" variantLength="23" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.(?_180707368)_(180707390_?)del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.(?_180707368)_(180707390_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000003.11:g.(?_180707368)_(180707390_?)del AND 3-methylglutaconic aciduria type 5" Accession="RCV001982989" Version="5">
        <ClassifiedConditionList TraitSetID="493">
          <ClassifiedCondition DB="MedGen" ID="C1857776">3-methylglutaconic aciduria type 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-07" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16055927</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27928778</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="493" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="108" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CARDIOMYOPATHY, DILATED, WITH ATAXIA</ElementValue>
                <XRef Type="MIM" ID="610198" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MGA, TYPE V</ElementValue>
                <XRef Type="MIM" ID="610198" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">3-methylglutaconic aciduria type V</ElementValue>
                <XRef ID="3-methylglutaconic+aciduria+type+V/7607" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">3 alpha methylglutaconic aciduria type V</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MGA 5</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">3-methylglutaconic aciduria type 5</ElementValue>
                <XRef ID="MONDO:0012435" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MGCA5</ElementValue>
                <XRef Type="MIM" ID="610198" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MGA5</ElementValue>
                <XRef Type="MIM" ID="610198" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DCMA</ElementValue>
                <XRef Type="MIM" ID="610198" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12964" />
                <XRef ID="12964" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-OH.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C5-OH Acylcarnitine, Organic Acidemias, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-OH-Elevated.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Organic Acidemias: Elevated C5-OH, 2022</CitationText>
              </Citation>
              <XRef ID="66634" DB="Orphanet" />
              <XRef ID="C1857776" DB="MedGen" />
              <XRef ID="MONDO:0012435" DB="MONDO" />
              <XRef Type="MIM" ID="610198" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4262365" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NM_145261.3_3_Deletion (exon 1)|MedGen:C1857776" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002239687" DateUpdated="2024-06-09" DateCreated="2022-03-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16055927</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27928778</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 1 of the DNAJC19 gene, which includes the initiator codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DNAJC19 are known to be pathogenic (PMID: 16055927, 27928778). This variant has not been reported in the literature in individuals affected with DNAJC19-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DNAJC19" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.(?_180707368)_(180707390_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1857776" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4262365" TraitType="Disease" MappingType="XRef" MappingValue="C1857776" MappingRef="MedGen">
        <MedGen CUI="C1857776" Name="3-methylglutaconic aciduria type 5" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

